Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of most influential co-occurring gene suites for gastrointestinal cancer using biomedical literature mining and graph-based influence maximization. | BMC Med Inform Decis Mak | 2020 | 32883271 | PubTator, text mining | PubMed |
| WDHD1 facilitates G1 checkpoint abrogation in HPV E7 expressing cells by modulating GCN5. | BMC Cancer | 2020 | 32883234 | PubTator, text mining | PubMed |
| Warsaw Breakage Syndrome associated DDX11 helicase resolves G-quadruplex structures to support sister chromatid cohesion. | Nat Commun | 2020 | 32855419 | PubTator, text mining | PubMed |
| Harnessing DNA Replication Stress for Novel Cancer Therapy. | Genes (Basel) | 2020 | 32854236 | PubTator, text mining | PubMed |
| USP7 Is a Master Regulator of Genome Stability. | Front Cell Dev Biol | 2020 | 32850836 | PubTator, text mining | PubMed |
| Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned? | Front Oncol | 2020 | 32850313 | PubTator, text mining | PubMed |
| Genome-Wide Transcriptional Regulation of the Long Non-coding RNA Steroid Receptor RNA Activator in Human Erythroblasts. | Front Genet | 2020 | 32849830 | PubTator, text mining | PubMed |
| Structural mechanism for replication origin binding and remodeling by a metazoan origin recognition complex and its co-loader Cdc6. | Nat Commun | 2020 | 32848132 | PubTator, text mining | PubMed |
| Distinct and sequential re-replication barriers ensure precise genome duplication. | PLoS Genet | 2020 | 32841231 | PubTator, text mining | PubMed |
| OscoNet: inferring oscillatory gene networks. | BMC Bioinformatics | 2020 | 32838730 | PubTator, text mining | PubMed |
| Investigation of the Mechanism of Shengmai Injection on Sepsis by Network Pharmacology Approaches. | Evid Based Complement Alternat Med | 2020 | 32831866 | PubTator, text mining | PubMed |
| ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway. | Cancer Res | 2020 | 32826278 | PubTator, text mining | PubMed |
| Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells. | Biomedicines | 2020 | 32825120 | PubTator, text mining | PubMed |
| YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms. | Cancers (Basel) | 2020 | 32823952 | PubTator, text mining | PubMed |
| Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer. | Cancers (Basel) | 2020 | 32823571 | PubTator, text mining | PubMed |
| Transcriptional Profiling and Biological Pathway(s) Analysis of Type 2 Diabetes Mellitus in a Pakistani Population. | Int J Environ Res Public Health | 2020 | 32823525 | PubTator, text mining | PubMed |
Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell lines. | Cancer Cell Int | 2020 | 32817744 | PubTator, text mining | PubMed |
| The dynamic nature of the human origin recognition complex revealed through five cryoEM structures. | Elife | 2020 | 32808929 | PubTator, text mining | PubMed |
| UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. | Nat Cell Biol | 2020 | 32807901 | PubTator, text mining | PubMed |
| MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer. | Cancers (Basel) | 2020 | 32806777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=58